US 11,701,255 B2
Treating eye diseases by deploying a stent
Robert Vidlund, Forest Lake, MN (US); Michael Calhoun, Lighthouse Point, FL (US); and Jeff Franco, Plano, TX (US)
Assigned to J.D. FRANCO & CO., LLC, Plano, TX (US)
Filed by J.D. Franco & Co., LLC, Plano, TX (US)
Filed on Aug. 19, 2020, as Appl. No. 16/997,513.
Application 16/997,513 is a continuation of application No. 16/151,741, filed on Oct. 4, 2018, granted, now 10,779,929.
Claims priority of provisional application 62/568,862, filed on Oct. 6, 2017.
Prior Publication US 2021/0169633 A1, Jun. 10, 2021
Int. Cl. A61F 9/007 (2006.01); A61F 2/06 (2013.01); A61F 2/856 (2013.01); A61F 2/14 (2006.01); A61F 2/915 (2013.01); A61F 2/82 (2013.01)
CPC A61F 9/007 (2013.01) [A61F 2/06 (2013.01); A61F 2/856 (2013.01); A61F 2/14 (2013.01); A61F 2/915 (2013.01); A61F 2002/068 (2013.01); A61F 2002/821 (2013.01); A61F 2210/0014 (2013.01); A61F 2230/0067 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method of treating an eye of a subject, the method comprising:
positioning an expandable strut structure within an ophthalmic artery or an ostium at a junction between an internal carotid artery and the ophthalmic artery of the subject, wherein the expandable strut structure has a first end and a second end having one or more holding elements, and wherein the expandable strut structure tapers from the first end toward the second end; and
seating the first end of the expandable strut structure closer to the internal carotid artery than the second end of the expandable strut structure, and seating the second end having the one or more holding elements within a short limb of the ophthalmic artery,
wherein treating the eye includes treating at least one disease or condition of the eye, wherein the at least one disease or condition includes macular degeneration.